Posts
Ethics and
Value Challenges in Antibiotic Resistance Management, Policy and Research,
symposium in Gothenburg, November 15-16, 2017. Save the date!
The World
Health Organization identifies antibiotic resistance as a global challenge so
serious that it threatens the fundamental achievement of modern medicine.
Ethics and value conflicts are at the centre of this challenge: understanding
its nature and stakes, identifying adequate social responses, understanding why
policies and actions can be more or less accepted by stakeholders. Underlying
issues regard conflict between individual interests and long term interests of
society; as well as national as opposed to global societal interests in the
short- and long term, how to manage the distribution of benefits and burdens
coming out of efforts to mitigate further resistance development and managing
consequences of established resistance, and responsibly balancing uncertainty
in the face of major public health threats.
The Centre for
Antibiotic Resistance Research (CARe) at the University of Gothenburg started
in 2016 as a cross disciplinary hub for research, education and public outreach
across six faculties, including collaboration with societal and private actors.
More information about CARe is found here: http://care.gu.se
 |
| The original CARe team at its inaugural conference in April 12016 |
Now CARe
presents a 2 day symposium on the theme of Ethics and Value Challenges
in Antibiotic Resistance Management, Policy and Research, November 15-16,
2017. This symposium will house up to 300 participants,
and assemble internationally excellent keynote presenters in ethics, law,
public health and related areas engaged on this topic – including leaders of
recently started major research projects– from Australia, Canada, the
Netherlands, Germany, Sweden, the United Kingdom, and the USA (see program below). The conference is open
and free of charge, but will require pre-registration, details of how to
register will follow.
Preliminary
program (all speakers confirmed):
DAY 1
Otto Cars
(Uppsala University): Global political response to the antiobiotic resistance
challenge
Michael J.
Selgelid (Monash University and WHO): Ethics and value challenges created by
antibiotic resistance: a roadmap
Marcel Verweij
(Wagenigen University): What is responsible care for ABR carriers?
Clare Chandler
(London School of Hygiene & Tropical Medicine): What is care in the wake of
antibiotics? Experiences of global health in low resource settings.
Michael Millar
(Queen Mary University of London): Antibiotic resistance: a threat to
capability security
Jonathan
Anomaly (UNC Chapel Hill & Duke University): Antibiotic resistance is a
public goods problem
DAY 2
Julian
Savulescu (University of Oxford): Collective responsibility and its ethical
implication related to ABR
Steven J. Hoffman
(University of Ottawa): What is required of effective legal mechanisms in the
ABR area?
Jasper Littmann
(Robert Koch Institute): Institutional ethics when responding to global
security threats, such as ABR
Alena Buyx
(Christian-Albrechts University of Kiel): How should policy makers, business
and professional practitioners think about the ethical aspects of ABR
management?
Christian
Munthe (University of Gothenburg): Do we have reason to adjust standard
precautionary rules for introduction of new interventions and methods in ABR
policy and other public health emergency settings?
Sverker Jagers
(University of Gothenburg): The role of public trust to balance ethics and
effectiveness in the implementation of global political action
Organizers: Joakim Larsson (director of CARe),
Christian Munthe (PI for ethics in CARe), and the CARe steering committee.
